Primary Care Pod podcast

New(ish) Drug for MACE Prevention

0:00
15:30
Rewind 15 seconds
Fast Forward 15 seconds

Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention).  NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.

 

 

More episodes from "Primary Care Pod"